Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Year: 1995
Type: article
Source: PubMed
Authors: N Yan, C Ricca, J Fletcher, T Glover, B R Seizinger, V Manne
Institutions: Bristol-Myers Squibb (United States), Harvard University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1504111015
